Currently predicting for Thu, 4 Jun 2026

LLY Prediction Chart

LLY Predictions History

Latest community submissions for LLY.
Predictor Target Session Target Price Result Direction Accuracy Score
Dec 3, 2024 $790.59 -1.15% $813.50 X 97.18% 0
Dec 3, 2024 $794.13 -0.71% $813.50 X 97.62% 0
Dec 3, 2024 Bullish $813.50 V 1
Nov 25, 2024 $737.67 -1.38% $754.25 X 97.80% 0
Nov 25, 2024 $754.12 +0.82% $754.25 V 99.98% 10
Nov 25, 2024 Bullish $754.25 V 1
Oct 31, 2024 $856.67 +1.16% $829.74 X 96.75% 0
Oct 31, 2024 $852.98 +0.73% $829.74 X 97.20% 0
Oct 31, 2024 $851.00 +0.49% $829.74 X 97.44% 0
Oct 31, 2024 Bullish $829.74 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LLY with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ELI LILLY AND COMPANY
Eli Lilly
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE